Chronic Cough Global Market Report 2025

Description

Chronic cough is characterized by persistent coughing lasting eight weeks or more, often indicative of an underlying condition such as asthma, allergies, or respiratory infections.

The primary drug classes for chronic cough include antihistamines, corticosteroids, decongestants, combination drugs, antibiotics, acid blockers, and others. Antihistamines are medications designed to address allergies by counteracting the physiological effects of histamines. These drugs can be administered through various routes, including oral, inhalational, injectable, and others, catering to settings such as hospitals, homecare, specialty centers, and more. Distribution channels for chronic cough medications encompass hospital pharmacies, online pharmacies, and retail pharmacies.

The chronic cough market research report is one of a series of new reports from The Business Research Company that provides chronic cough market statistics, including chronic cough industry global market size, regional shares, competitors with a chronic cough market share, detailed chronic cough market segments, market trends and opportunities, and any further data you may need to thrive in the chronic cough industry. This chronic cough market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The chronic cough market size has grown strongly in recent years. It will grow from $8.22 billion in 2024 to $8.9 billion in 2025 at a compound annual growth rate (CAGR) of 8.3%. The growth in the historic period can be attributed to prevalence of underlying respiratory conditions, environmental factors and air pollution, smoking and tobacco use, respiratory infections, allergies and environmental sensitivities

The chronic cough market size is expected to see strong growth in the next few years. It will grow to $12.89 billion in 2029 at a compound annual growth rate (CAGR) of 9.7%. The growth in the forecast period can be attributed to emerging therapies targeting specific pathways, increasing understanding of reflux-related cough, global efforts in smoking cessation, environmental and occupational health policies. Major trends in the forecast period include advancements in diagnostic technologies, patient-centric approaches, therapeutic innovations in neurogenic cough, telehealth for chronic cough management, research on central sensitization.

The surge in the prevalence of cough incidents is anticipated to drive the expansion of the chronic cough market in the foreseeable future. Coughing is a natural reflex that expels irritants or foreign substances from the airways, and when it persists for a duration exceeding eight weeks, it is termed as chronic. The increase in overall cough instances directly correlates with the rise in chronic cough cases. For example, as per March 2022 data from Florida Health, the US reported a total of 80 cases in 2021, marking an incidence of 41.0 and 1.4 per 100,000 individuals for cough and pertussis cases, respectively. Similarly, findings from the Statens Serum Institut in Denmark revealed a 41% increase in pertussis cases from November 2022 to April 2023 compared to the previous year. This escalating prevalence of cough-related conditions, notably pertussis, is a driving force behind the chronic cough market's growth.

The rising prevalence of smoking and tobacco use is projected to drive the growth of the chronic cough market in the future. Smoking involves burning a substance, usually tobacco, and inhaling or absorbing the resulting smoke into the bloodstream. This practice irritates the airways, contributes to chronic bronchitis, increases mucus production, diminishes lung function, weakens the immune system, interferes with the cough reflex, and raises the risk of lung cancer. For example, in September 2024, the Centers for Disease Control and Prevention (CDC), a U.S.-based national public health agency, reported that in 2022, 49.2 million adults (19.8%) in the U.S.-nearly 1 in 5-indicated current use of tobacco products. Therefore, the growing prevalence of smoking and tobacco consumption is driving the expansion of the chronic cough market.

Major companies in the chronic cough market are focusing on developing innovative products like biosimilars to enhance their market position. Biosimilars are used to treat conditions such as cancer, autoimmune diseases, and diabetes, providing cost-effective alternatives to existing biologics. For example, in July 2024, Sandoz, a Switzerland-based pharmaceutical company, launched its biosimilar Pyzchiva (ustekinumab) across Europe, aimed at treating chronic inflammatory diseases like plaque psoriasis, psoriatic arthritis, and Crohn's disease. This biosimilar is particularly noteworthy as it is the first of its kind available in Europe with all strengths of the reference medicine, including the initiation dose for Crohn's disease. Developed in collaboration with Samsung Bioepis, Sandoz intends to improve access to effective treatments for millions affected by these conditions. The launch underscores Sandoz's commitment to offering affordable healthcare solutions and enhancing the quality of life for patients throughout Europe.

Leading enterprises in the chronic cough sector are emphasizing technologically advanced products such as cough detectors to drive market growth. Cough detection entails the identification and categorization of cough sounds using cutting-edge technologies such as artificial intelligence (AI) and machine learning. For instance, in May 2023, Hyfe Inc., a US-based company specializing in acoustic epidemiology with a focus on analyzing health sounds, particularly coughs, introduced a digital therapeutic. This innovative digital therapeutic aims to improve patients' lives by providing comprehensive care for chronic cough sufferers. Leveraging Hyfe's expertise in cough monitoring and its extensive database of over 700 million sounds, this digital therapy offers an end-to-end solution for managing coughs. By integrating speech therapy for cough treatment and suppression alongside breathing exercises accessible via mobile devices, this digital therapeutic addresses the needs of chronic cough patients.

In September 2022, the US-based biopharmaceutical company Pfizer Inc. successfully acquired the ASX-listed digital health startup ResApp Health for $115 million. This strategic acquisition was undertaken by Pfizer to strengthen its product portfolio and extend its footprint in key healthcare technology domains. ResApp is a smartphone application known for analyzing coughing patterns, accurately identifying respiratory conditions such as asthma, pneumonia, bronchiolitis, croup, and chronic obstructive pulmonary disease (COPD). ResApp Health, headquartered in Australia, is a healthcare solutions company that specializes in the management of chronic cough. This acquisition reflects Pfizer's commitment to leveraging innovative digital health solutions for enhanced healthcare offerings.

Major companies operating in the chronic cough market include Tris Pharma Inc., Pfizer Inc., Johnson & Johnson Co, Bayer AG, Novartis AG, Sanofi SA, Bristol-Myers Squibb Company, AstraZeneca plc, Glaxo SmithKline Plc, Merck KGaA, Reckitt Benckiser Group plc, Glenmark Pharmaceuticals Ltd, Teva Pharmaceutical Industries Ltd., Mylan NV, Aurobindo Pharma Ltd., Cipla Limited, Apotex Inc., Hikma Pharmaceuticals Plc, Amneal Pharmaceuticals LLC, Mount Sinai Health System, Biocon Ltd., BELLUS Health Inc., Trevi Therapeutics Inc., Sun Pharmaceutical Industries Ltd., NeRRe Therapeutics Ltd.

North America was the largest region in the chronic cough market in 2024. The regions covered in the chronic cough market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the chronic cough market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The chronic cough market consists of revenues earned by entities by providing services such as chest X-ray or CT scan services, lung function tests, and sputum culture. The market value includes the value of related goods sold by the service provider or included within the service offering. The chronic cough market also includes sales of cough suppressants, expectorants, inhalers, and allergy medications which are used in providing the services. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Chronic Cough Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on chronic cough market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for chronic cough ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The chronic cough market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:1) By Drug Class: Antihistamines; Corticosteroids; Decongestants; Combination Drug; Antibiotics; Acid Blockers; Other Drug Classes
2) By Route Of Administration: Oral; Inhalational; Injectable; Other Route Of Administrations
3) By End-Users: Hospitals; Homecare; Specialty Centers; Other End Users
4) By Distribution Channel: Hospital Pharmacy; Online Pharmacy; Retail Pharmacy
Subsegments:
1) By Antihistamines: First-Generation Antihistamines; Second-Generation Antihistamines
2) By Corticosteroids: Inhaled Corticosteroids; Systemic Corticosteroids
3) By Decongestants: Oral Decongestants; Nasal Decongestants
4) By Combination Drug: Antihistamine And Decongestant Combinations; Cough Suppressant And Expectorant Combinations
5) By Antibiotics: Macrolides; Penicillins; Cephalosporins
6) By Acid Blockers: Proton Pump Inhibitors (PPIs); H2-Receptor Antagonists
7) By Other Drug Classes: Mucolytics; Cough Suppressants; Herbal Remedies
Companies Mentioned: Tris Pharma Inc.; Pfizer Inc.; Johnson & Johnson Co; Bayer AG; Novartis AG
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery format: PDF, Word and Excel Data Dashboard.

Product Code: r24792

1. Executive Summary

2. Chronic Cough Market Characteristics

3. Chronic Cough Market Trends And Strategies

4. Chronic Cough Market - Macro Economic Scenario including the impact of Interest Rates, Inflation, Geopolitics and Covid And Recovery on the Market

5. Global Chronic Cough Growth Analysis And Strategic Analysis Framework

5.1. Global Chronic Cough PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
5.2. Analysis Of End Use Industries
5.3. Global Chronic Cough Market Growth Rate Analysis
5.4. Global Chronic Cough Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
5.5. Global Chronic Cough Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
5.6. Global Chronic Cough Total Addressable Market (TAM)

6. Chronic Cough Market Segmentation

6.1. Global Chronic Cough Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Antihistamines
Corticosteroids
Decongestants
Combination Drug
Antibiotics
Acid Blockers
Other Drug Classes
6.2. Global Chronic Cough Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Oral
Inhalational
Injectable
Other Route Of Administrations
6.3. Global Chronic Cough Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Hospitals
Homecare
Specialty Centers
Other End Users
6.4. Global Chronic Cough Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Hospital Pharmacy
Online Pharmacy
Retail Pharmacy
6.5. Global Chronic Cough Market, Sub-Segmentation Of Antihistamines, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
First-Generation Antihistamines
Second-Generation Antihistamines
6.6. Global Chronic Cough Market, Sub-Segmentation Of Corticosteroids, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Inhaled Corticosteroids
Systemic Corticosteroids
6.7. Global Chronic Cough Market, Sub-Segmentation Of Decongestants, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Oral Decongestants
Nasal Decongestants
6.8. Global Chronic Cough Market, Sub-Segmentation Of Combination Drug, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Antihistamine And Decongestant Combinations
Cough Suppressant And Expectorant Combinations
6.9. Global Chronic Cough Market, Sub-Segmentation Of Antibiotics, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Macrolides
Penicillins
Cephalosporins
6.10. Global Chronic Cough Market, Sub-Segmentation Of Acid Blockers, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Proton Pump Inhibitors (PPIs)
H2-Receptor Antagonists
6.11. Global Chronic Cough Market, Sub-Segmentation Of Other Drug Classes, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Mucolytics
Cough Suppressants
Herbal Remedies

7. Chronic Cough Market Regional And Country Analysis

7.1. Global Chronic Cough Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
7.2. Global Chronic Cough Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Chronic Cough Market

8.1. Asia-Pacific Chronic Cough Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Chronic Cough Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.3. Asia-Pacific Chronic Cough Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.4. Asia-Pacific Chronic Cough Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Chronic Cough Market

9.1. China Chronic Cough Market Overview
9.2. China Chronic Cough Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.3. China Chronic Cough Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.4. China Chronic Cough Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Chronic Cough Market

10.1. India Chronic Cough Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.2. India Chronic Cough Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.3. India Chronic Cough Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Chronic Cough Market

11.1. Japan Chronic Cough Market Overview
11.2. Japan Chronic Cough Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.3. Japan Chronic Cough Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.4. Japan Chronic Cough Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Chronic Cough Market

12.1. Australia Chronic Cough Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.2. Australia Chronic Cough Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.3. Australia Chronic Cough Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Chronic Cough Market

13.1. Indonesia Chronic Cough Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.2. Indonesia Chronic Cough Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.3. Indonesia Chronic Cough Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Chronic Cough Market

14.1. South Korea Chronic Cough Market Overview
14.2. South Korea Chronic Cough Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.3. South Korea Chronic Cough Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.4. South Korea Chronic Cough Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Chronic Cough Market

15.1. Western Europe Chronic Cough Market Overview
15.2. Western Europe Chronic Cough Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.3. Western Europe Chronic Cough Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.4. Western Europe Chronic Cough Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Chronic Cough Market

16.1. UK Chronic Cough Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.2. UK Chronic Cough Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.3. UK Chronic Cough Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Chronic Cough Market

17.1. Germany Chronic Cough Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.2. Germany Chronic Cough Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.3. Germany Chronic Cough Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Chronic Cough Market

18.1. France Chronic Cough Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.2. France Chronic Cough Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.3. France Chronic Cough Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Chronic Cough Market

19.1. Italy Chronic Cough Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.2. Italy Chronic Cough Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.3. Italy Chronic Cough Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Chronic Cough Market

20.1. Spain Chronic Cough Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.2. Spain Chronic Cough Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.3. Spain Chronic Cough Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Chronic Cough Market

21.1. Eastern Europe Chronic Cough Market Overview
21.2. Eastern Europe Chronic Cough Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.3. Eastern Europe Chronic Cough Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.4. Eastern Europe Chronic Cough Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Chronic Cough Market

22.1. Russia Chronic Cough Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.2. Russia Chronic Cough Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.3. Russia Chronic Cough Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Chronic Cough Market

23.1. North America Chronic Cough Market Overview
23.2. North America Chronic Cough Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.3. North America Chronic Cough Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.4. North America Chronic Cough Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Chronic Cough Market

24.1. USA Chronic Cough Market Overview
24.2. USA Chronic Cough Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.3. USA Chronic Cough Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.4. USA Chronic Cough Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Chronic Cough Market

25.1. Canada Chronic Cough Market Overview
25.2. Canada Chronic Cough Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.3. Canada Chronic Cough Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.4. Canada Chronic Cough Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Chronic Cough Market

26.1. South America Chronic Cough Market Overview
26.2. South America Chronic Cough Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.3. South America Chronic Cough Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.4. South America Chronic Cough Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Chronic Cough Market

27.1. Brazil Chronic Cough Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.2. Brazil Chronic Cough Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.3. Brazil Chronic Cough Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Chronic Cough Market

28.1. Middle East Chronic Cough Market Overview
28.2. Middle East Chronic Cough Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.3. Middle East Chronic Cough Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.4. Middle East Chronic Cough Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Chronic Cough Market

29.1. Africa Chronic Cough Market Overview
29.2. Africa Chronic Cough Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.3. Africa Chronic Cough Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.4. Africa Chronic Cough Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Chronic Cough Market Competitive Landscape And Company Profiles

30.1. Chronic Cough Market Competitive Landscape
30.2. Chronic Cough Market Company Profiles
- 30.2.1. Tris Pharma Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.2. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.3. Johnson & Johnson Co Overview, Products and Services, Strategy and Financial Analysis
- 30.2.4. Bayer AG Overview, Products and Services, Strategy and Financial Analysis
- 30.2.5. Novartis AG Overview, Products and Services, Strategy and Financial Analysis

31. Chronic Cough Market Other Major And Innovative Companies

31.1. Sanofi SA
31.2. Bristol-Myers Squibb Company
31.3. AstraZeneca plc
31.4. Glaxo SmithKline Plc
31.5. Merck KGaA
31.6. Reckitt Benckiser Group plc
31.7. Glenmark Pharmaceuticals Ltd
31.8. Teva Pharmaceutical Industries Ltd.
31.9. Mylan NV
31.10. Aurobindo Pharma Ltd.
31.11. Cipla Limited
31.12. Apotex Inc.
31.13. Hikma Pharmaceuticals Plc
31.14. Amneal Pharmaceuticals LLC
31.15. Mount Sinai Health System

32. Global Chronic Cough Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Chronic Cough Market

34. Recent Developments In The Chronic Cough Market

35. Chronic Cough Market High Potential Countries, Segments and Strategies

35.1 Chronic Cough Market In 2029 - Countries Offering Most New Opportunities
35.2 Chronic Cough Market In 2029 - Segments Offering Most New Opportunities
35.3 Chronic Cough Market In 2029 - Growth Strategies
- 35.3.1 Market Trend Based Strategies
- 35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations
36.2. Currencies
36.3. Historic And Forecast Inflation Rates
36.4. Research Inquiries
36.5. The Business Research Company
36.6. Copyright And Disclaimer